Synthesis of resveratrol derivatives as new analgesic drugs through desensitization of the TRPA1 receptor.

Bioorg Med Chem Lett

School of Pharmacy, Hyogo University of Health Sciences, 1-3-6 Minatojima, Kobe 650-8530, Japan; Traditional Medicine Research Center, Chinese Medicine Confucius Institute at Hyogo College of Medicine, Kobe 650-8530, Japan; Department of Anatomy and Neuroscience, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan. Electronic address:

Published: July 2017

AI Article Synopsis

  • * Most derivatives functioned similarly to resveratrol or AITC, acting as activators and desensitizers of the TRPA1 channel.
  • * Notably, compound 4z (HUHS029) displayed stronger inhibitory effects on TRPA1 than resveratrol, and it showed potential pain-relieving effects in live animal tests.

Article Abstract

A series of 31 resveratrol derivatives was designed, synthesized and evaluated for activation and inhibition of the TRPA1 channel. Most acted as activators and desensitizers of TRPA1 channels like resveratrol or allyl isothiocyanate (AITC). Compound 4z (HUHS029) exhibited higher inhibitory activity than resveratrol with an IC value of 16.1μM. The activity of 4z on TRPA1 was confirmed in TRPA1-expressing HEK293 cells, as well as in rat dorsal root ganglia neurons by a whole cell patch clamp recording. Furthermore, pretreatment with 4z exhibited an analgesic effect on AITC-evoked TRPA1-related pain behavior in vivo.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2017.05.025DOI Listing

Publication Analysis

Top Keywords

resveratrol derivatives
8
synthesis resveratrol
4
derivatives analgesic
4
analgesic drugs
4
drugs desensitization
4
trpa1
4
desensitization trpa1
4
trpa1 receptor
4
receptor series
4
series resveratrol
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!